To include your compound in the COVID-19 Resource Center, submit it here.

Product Development
Four late-stage COVID-19 vaccine trial protocols harmonized, Fauci says

In a live-streamed conversation, NIH director Francis Collins and NIAID director Anthony Fauci discussed progress in standardizing protocols of Phase III trials for COVID-19 ...

NASH ups and downs, COVID-19 vaccines & real-world data for diagnostics: a BioCentury podcast

The path to authorization for COVID-19 vaccines is beginning to take shape as FDA lays out its requirements and early data begin to trickle in. On the latest edition of the ...

U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership

The U.K. is reportedly in talks to secure access to a second COVID-19 vaccine, this time from GlaxoSmithKline and Sanofi, as concerns grow over vaccine nationalism.

Data Bytes: COVID-19 pipeline growth continues to flatten

This week, eight COVID-19 countermeasures entered the pipeline, down from 16 entrants last week. BioCentury’s COVID-19 Resource ...

July 6 Quick Takes: Cellectis CAR T trial halted; plus data readouts from Bellus, ObsEva, Idorsia, and more

Patient death prompts Cellectis trial halt
FDA placed a clinical hold on an allogeneic CAR T therapy trial to treat multiple myeloma from Cellectis S.A. ...

Politics, Policy & Law
Trump to sign drug pricing order, chief of staff says

President Donald Trump will sign executive orders this week on drug pricing, bringing manufacturing back to the U.S., and immigration, White House Chief of Staff Mark Meadows said ...

Data Bytes: 1H20 life sciences funding nearly matches all of 2019

The first half of the

Read the full 51 word article

BioCentury ISSN 1097-7201